Please assess the completion status of the following clinical trial:

Trial Title: Confocal Endomicroscopy for Barrett's Esophagus

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Barrett's esophagus or suspected Barrett's-associated neoplasia~* Age \> 18~* Able to give informed consent~Exclusion Criteria:~* Known advanced malignant disease~* Allergy to the fluorescent contrast agent fluorescein sodium~* Coagulopathy or bleeding disorder

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- CLE followed by standard EGD (Type: ACTIVE_COMPARATOR): Participants are randomized to have either confocal laser endomicroscopy (CLE) or standard endoscopy (EGD) first. Then 6 weeks later, they have the other procedure. This arm is for patients randomized to CLE followed by standard EGD
- standard EGD followed by CLE (Type: ACTIVE_COMPARATOR): Patients are randomized to either have standard endoscopy (EGD)or confocal laser endomicroscopy (CLE) first. The second procedure is then completed 6 weeks later. This arm is for patients who had standard endoscopy first.

Based on this trial design, predict the completion outcome and termination type (if applicable).